NYSE:CNC - Centene Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$125.27 -1.19 (-0.94 %)
(As of 01/18/2019 08:33 AM ET)
Previous Close$126.46
Today's Range$124.56 - $126.32
52-Week Range$97.61 - $148.98
Volume990,762 shs
Average Volume1.74 million shs
Market Capitalization$25.97 billion
P/E Ratio24.90
Dividend YieldN/A
Beta1.27
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Receive CNC News and Ratings via Email

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP15135B10
Phone314-725-4477

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$48.38 billion
Cash Flow$7.1747 per share
Book Value$39.78 per share

Profitability

Net Income$828 million

Miscellaneous

Employees33,700
Market Cap$25.97 billion
OptionableOptionable

Centene (NYSE:CNC) Frequently Asked Questions

What is Centene's stock symbol?

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

How were Centene's earnings last quarter?

Centene Corp (NYSE:CNC) issued its earnings results on Tuesday, October, 23rd. The company reported $1.79 EPS for the quarter, topping the consensus estimate of $1.77 by $0.02. The business earned $16.18 billion during the quarter, compared to the consensus estimate of $15.93 billion. Centene had a return on equity of 14.42% and a net margin of 1.58%. The firm's revenue was up 36.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.35 EPS. View Centene's Earnings History.

When is Centene's next earnings date?

Centene is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Centene.

How can I listen to Centene's earnings call?

Centene will be holding an earnings conference call on Tuesday, February 5th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8778830383.

What guidance has Centene issued on next quarter's earnings?

Centene issued an update on its FY19 earnings guidance on Thursday, December, 13th. The company provided EPS guidance of $8.15 to $8.55 for the period, compared to the Thomson Reuters consensus estimate of $8.36. The company issued revenue guidance of $69.7 billion to $70.5 billion, compared to the consensus revenue estimate of $70.10 billion.Centene also updated its FY18 guidance to $6.90 to $7.10 EPS.

What price target have analysts set for CNC?

14 Wall Street analysts have issued 12 month price targets for Centene's shares. Their forecasts range from $142.00 to $175.00. On average, they expect Centene's share price to reach $156.4369 in the next year. This suggests a possible upside of 24.9% from the stock's current price. View Analyst Price Targets for Centene.

What is the consensus analysts' recommendation for Centene?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.

What are Wall Street analysts saying about Centene stock?

Here are some recent quotes from research analysts about Centene stock:
  • 1. According to Zacks Investment Research, "Centene’s shares have outperformed its industry’s gain in a year’s time. Its earnings have been supported by the acquisition of Fidelis Care, growth in the health insurance marketplace business, expansion in new programs in many of its states. A number of Medicaid and Medicare contract wins should lead to membership growth. Its strong cash flow generation capacity aids investment in business. The increase in earnings guidance for 2018 instills investor’s confidence in the company. Nevertheless, rising operating costs remains a concern. Also high debt level increases leverage risk." (1/16/2019)
  • 2. Cantor Fitzgerald analysts commented, "We rate Centene Corporation (CNC) DCF-based price target of $145 per share. We continue to view Medicaid as a good growth opportunity. At the same time, CNC is building its Medicare Advantage business, increasing its footprint in individual exchange markets (and doing it profitably) and increasing its specialty offerings. $145 per share 12-month price target is based on DCF analysis." (12/13/2018)

Has Centene been receiving favorable news coverage?

Press coverage about CNC stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Centene earned a daily sentiment score of 0.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days.

Who are some of Centene's key competitors?

Who are Centene's key executives?

Centene's management team includes the folowing people:
  • Mr. Michael Frederic Neidorff, Chairman & CEO (Age 75)
  • Ms. Cynthia J. Brinkley, Pres , COO, Chief Admin. & Markets Officer (Age 58)
  • Mr. Jeffrey Alan Schwaneke CPA, CPA, Exec., CFO & Treasurer (Age 42)
  • Mr. Keith Harvey Williamson, Exec. VP, Gen. Counsel & Corp. Sec. (Age 66)
  • Mr. Jesse N. Hunter, Exec. VP & Chief Strategy Officer (Age 42)

Who are Centene's major shareholders?

Centene's stock is owned by many different of institutional and retail investors. Top institutional investors include Scout Investments Inc. (0.15%), Nisa Investment Advisors LLC (0.06%), Hennessy Advisors Inc. (0.03%), Sit Investment Associates Inc. (0.02%), Gulf International Bank UK Ltd (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Richard A Gephardt, Robert K Ditmore and Stephen Wallace. View Institutional Ownership Trends for Centene.

Which institutional investors are selling Centene stock?

CNC stock was sold by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd, Nisa Investment Advisors LLC, Hennessy Advisors Inc., State of Alaska Department of Revenue, Sit Investment Associates Inc., Boston Advisors LLC, Louisiana State Employees Retirement System and Fulton Bank N.A.. Company insiders that have sold Centene company stock in the last year include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Keith H Williamson, Mark J Brooks, Michael F Neidorff and Robert K Ditmore. View Insider Buying and Selling for Centene.

Which institutional investors are buying Centene stock?

CNC stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., CHURCHILL MANAGEMENT Corp, QUANTRES ASSET MANAGEMENT Ltd, Virtu Financial LLC, Highland Capital Management LLC, Oakbrook Investments LLC, First Hawaiian Bank and Private Trust Co. NA. View Insider Buying and Selling for Centene.

How do I buy shares of Centene?

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Centene's stock price today?

One share of CNC stock can currently be purchased for approximately $125.27.

How big of a company is Centene?

Centene has a market capitalization of $25.97 billion and generates $48.38 billion in revenue each year. The company earns $828 million in net income (profit) each year or $5.03 on an earnings per share basis. Centene employs 33,700 workers across the globe.

What is Centene's official website?

The official website for Centene is http://www.centene.com.

How can I contact Centene?

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]


MarketBeat Community Rating for Centene (NYSE CNC)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  792 (Vote Outperform)
Underperform Votes:  512 (Vote Underperform)
Total Votes:  1,304
MarketBeat's community ratings are surveys of what our community members think about Centene and other stocks. Vote "Outperform" if you believe CNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel